Regulations
Home Up Welcome News Alerts 5th Framework Hot Links Market debris Conference Reports Conference cont'd R&D Digest R&D news Regulations Book Reviews Contact details


Update on regulations and harmonisation

Progress is continuing towards a harmonised approach to certain aspects of devices and biomaterials, similar to the ICH for pharmaceuticals and biologicals. The European Commission and representatives of Canada, Australia and USA, are working on global harmonisation of the approval process for devices containing human tissues, the first stage of which is to establish common terminology and risk-categories.

CEN 12442, the standard for manufacture of medical devices containing animal tissues and derivatives, has been approved and will be published during 1999. For comments on European Standards see the contributions by Dr Julian Braybrook, Scientific Co-ordinator of the European Biomaterials Network, to the Biomatera Newsletter. Also see Newsletter Issue 3 - EU Standards and EU Regulations.

In the USA, manufacturers of medical devices, represented by HIMA (Health industry Manufacturers’ Association) and the FDA’s Center for Biologics Evaluation and Research CBER are in negotation about ways to improve CBER’s performance in the assessment of devices abnd diagnostics with biologic components. HIMA would like closer co-operation between CBER and HIMA representatives in drafting responsible procedures and guidance, as has occurred with the FDA’s Center for Devices and Radiological Health (CDRH) CDHR handles the approval process for devices that are not involved in high-risk blood processes such as transfusion, bone marrow implants, automated blood collection, HIV diagnosis.

The Global Harmonisation Task force is currently working to complete a Global Medical Device Nomenclature for the end of 1999, to replace the Universal Medical Device Nomenclature System. the global nomenclature will be used to encode all information about devices in the European Union into the European Medical Device Database EUDAMED. EUDAMED is being developed and finalised by the German medical data institute DIMDI and is currently going through a period of data validation and problem-solving. Once EUDAMED is fully-functional, it will carry information from manufacturers, Notified Bodies and Device agencies on devices, and will be extended to include in vitro diagnostics during the period up to the enactment of the IVD Directive in June 2000.

Although France appears to be taking a less rigorous line on implementation of its extremely strict draft laws on medical device regulation, it has banned mercury thermometers from 1st March 1999, because of the potential hazards from the glass structure and the mercury contents when the thermometers are used for measuring internal temperatures.

Back Up Next


All text and representations on this site © L P M Lloyd-Evans & BioBridge 2000-2005
mlloydevans@biobridge.co.uk.
Designed and managed by BioPortfolio Ltd on behalf of  L P M Lloyd-Evans & BioBridge Associates.

The foundation and maintenance of this site was made possible by EC funding in project BRRT-CT97-5008 1997-2000